Virus. When you hear the word, you probably shudder. But not all viruses are bad or cause disease. Some are even used for ...

In “a note of accompaniment” to the final document, the pope made clear that Catholic bishops throughout the world are to ...

CNS Pharmaceuticals (NASDAQ: CNSP) announced updated results from its ongoing pivotal trial evaluating Berubicin, a <a target=_blank href= ...

Alzheimer's disease is the biological process that begins with the appearance of a build-up of proteins in the form of ...

This study presents important findings on the role of CXXC-finger protein 1 in regulatory T cell gene regulation and function. The evidence supporting the authors' claims is solid, with mostly ...

To view the full press release, visit https://ibn.fm/NjZCs About CNS ... Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including ...

CNS Pharmaceuticals (NASDAQ: CNSP) announced that its abstract on the pivotal trial of Berubicin, a <a target=_blank href= ...

Election results indicate shifts among Catholics overall, especially white Catholics, as well as with Latino voters – and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Initiation of Phase 1b Study of GT-02287 in Parkinson's patients expected by end of 2024 BETHESDA, Md., Nov. 14, 2024 (GLOBE ...

Using analysis from an open-label, long-term treatment study of the RNS ® System, Rapport will present key new data on the correlation between the reduction in long episode (LE) frequency (abnormal ...

A groundbreaking seven-year study reveals how metagenomic sequencing offers a more accurate, comprehensive approach to diagnosing difficult CNS infections—spotting pathogens that traditional ...